134 related articles for article (PubMed ID: 28274314)
21. PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
Kar S; Wang M; Yao W; Michejda CJ; Carr BI
Mol Cancer Ther; 2006 Jun; 5(6):1511-9. PubMed ID: 16818510
[TBL] [Abstract][Full Text] [Related]
22. BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
Breunig C; Mueller BJ; Umansky L; Wahl K; Hoffmann K; Lehner F; Manns MP; Bantel H; Falk CS
Clin Cancer Res; 2014 May; 20(9):2410-23. PubMed ID: 24573550
[TBL] [Abstract][Full Text] [Related]
23. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
24. Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures.
Juhász T; Matta C; Somogyi C; Katona É; Takács R; Soha RF; Szabó IA; Cserháti C; Sződy R; Karácsonyi Z; Bakó E; Gergely P; Zákány R
Cell Signal; 2014 Mar; 26(3):468-82. PubMed ID: 24333667
[TBL] [Abstract][Full Text] [Related]
25. Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells.
Cao L; Zhang Z; Han L; Du J; Liang X; Liu Y; Sun W
Mol Med Rep; 2014 Apr; 9(4):1121-7. PubMed ID: 24535322
[TBL] [Abstract][Full Text] [Related]
26. MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.
Guégan JP; Ezan F; Théret N; Langouët S; Baffet G
Carcinogenesis; 2013 Jan; 34(1):38-47. PubMed ID: 23042098
[TBL] [Abstract][Full Text] [Related]
27. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
28. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
[TBL] [Abstract][Full Text] [Related]
29. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.
Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G
Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582
[TBL] [Abstract][Full Text] [Related]
30. [Study on synergistic effect of sodium cantharidinate combined with chemotherapeutic drugs on hepatic carcinoma and its effective mechanism].
Zhao RL; Chen MJ; Zhao FM; Xu DQ; Zhang X; Zhou KF
Zhong Yao Cai; 2014 Nov; 37(11):1938-46. PubMed ID: 26027111
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of Yiqi Jiedu formula on proliferation of nasopharyngeal carcinoma cells by MAPK/ERK signaling pathway].
Hu J; Dai N; Xu BY; Zhou FL; Lin T; Luo JJ; Fan JY; He YC
Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1221-1227. PubMed ID: 29676132
[TBL] [Abstract][Full Text] [Related]
32. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
[TBL] [Abstract][Full Text] [Related]
33. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
34. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
35. Microcystin-LR induces a wide variety of biochemical changes in the A549 human non-small cell lung cancer cell line: Roles for protein phosphatase 2A and its substrates.
Wang H; Xu K; Wang B; Liu J; Wang X; Xing M; Huang P; Guo Z; Xu L
Environ Toxicol; 2017 Mar; 32(3):1065-1078. PubMed ID: 27352821
[TBL] [Abstract][Full Text] [Related]
36. [Role of ERK/FoxO3a signal axis in inhibitory effect of vitexin 1 (VB-1) in HepG2 cell proliferation].
Zheng XX; Zhang RS; Zhou YJ; Wang JG
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1276-9. PubMed ID: 25011268
[TBL] [Abstract][Full Text] [Related]
37. Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo.
Lin W; Zhong M; Yin H; Chen Y; Cao Q; Wang C; Ling C
Oncol Rep; 2016 Aug; 36(2):961-7. PubMed ID: 27278720
[TBL] [Abstract][Full Text] [Related]
38. Study on the mechanism of AMPK signaling pathway and its effect on apoptosis of human hepatocellular carcinoma SMMC-7721 cells by curcumin.
Zhang YJ; Xiang H; Liu JS; Li D; Fang ZY; Zhang H
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):1144-1150. PubMed ID: 28338175
[TBL] [Abstract][Full Text] [Related]
39. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
40. [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].
Zheng ST; Liu T; Middottuersun A; Huo Q; Liu Q; Huang CG; Feng JG; Lü GD; Wang X; Lin RY; Sheyhidin I; Lu XM
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):421-5. PubMed ID: 21875481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
